Association between Current Smoking and Stent Thrombosis in Post-PCI Patients: A Clinical Observational Analysis
DOI:
https://doi.org/10.70749/ijbr.v3i3.885Keywords:
Smoking, Stent Thrombosis, Post-PCI, DAPT Adherence, PeshawarAbstract
Objective: To evaluate the relationship between smoking and the incidence of stent thrombosis in post-PCI patients and determine the impact of smoking on stent thrombosis incidence and examine DAPT adherence among smokers and non-smokers. Methodology: A retrospective analysis was conducted from January 2023 to December 2023, involving 200 post-PCI patients (100 smokers and 100 non-smokers). Demographic data, stent thrombosis incidence, and DAPT adherence were collected. Stent thrombosis was categorized into early, sub-acute, late, and no thrombosis. A chi-square test was used to assess the association between smoking and stent thrombosis. Results: Of the smokers, 58% (58 patients) developed stent thrombosis, compared to 18% (18 patients) of non-smokers. A chi-square test revealed a significant association between smoking and stent thrombosis (p = 0.0004). Regarding DAPT adherence, 55% of smokers showed poor adherence, while only 20% of non-smokers were non-adherent. The findings emphasize the higher stent thrombosis risk among smokers, potentially due to both physiological effects and poor adherence to medication. Conclusion: Smoking significantly increases the risk of stent thrombosis in post-PCI patients. Smoking cessation and better adherence to DAPT are crucial for improving patient outcomes. Future studies should focus on smoking cessation programs and better adherence monitoring post-PCI.
Downloads
References
Song Z, Kim M, Lee K, Jin X, Yuan S, Youk G, et al. the impact of smoking status on platelet reactivity and its association on clinical outcomes in east asian ami patients with stent implantation. Eur Heart J 2023. https://doi.org/10.1093/eurheartj/ehad655.1364.
Polo J, Balcones D, Fernandez A, Escribano J, Gavidia LL, Bernardo E, et al. impact of smoking habit on platelet reactivity in a cohort of patients admitted due to an acute coronary syndrome. Eur Heart J 2020;41. https://doi.org/10.1093/ehjci/ehaa946.1548.
Takahashi K, Thuijs D, Gao C, Ono M, Holmes D, Mack M, et al. ten-year all-cause mortality according to smoking status in patients with severe coronary artery disease undergoing surgical or percutaneous revascularization. Eur J Prev Cardiol 2020. https://doi.org/10.1093/eurjpc/zwaa089.
Shahim B, Redfors B, Chen S, Morice M, Gersh B, Puskas J, et al. outcomes after left main coronary artery revascularization by percutaneous coronary intervention or coronary artery bypass grafting according to smoking status. Am J Cardiol 2020. https://doi.org/10.1016/j.amjcard.2020.04.029.
Anghel L, Tudurachi B-S, Tudurachi A, Zăvoi A, Clement A, Roungos A, et al. patient-related factors predicting stent thrombosis in percutaneous coronary interventions. J Clin Med 2023;12. https://doi.org/10.3390/jcm12237367.
Nicolas J, Spirito A, Sartori S, Zhang Z, Pitaro N, Cao D, et al. abstract 12805: incidence and predictors of myocardial infarction or stent thrombosis in high-bleeding risk patients undergoing percutaneous coronary intervention. Circulation 2022. https://doi.org/10.1161/circ.146.suppl_1.12805.
Ahmed S, Khowaja S, Khowaja S, Ashraf T, Aamir K, Batra M, et al. differences in angiographic profile and immediate outcome of primary percutaneous coronary intervention in otherwise risk-free young male smokers. Cureus 2020;12. https://doi.org/10.7759/cureus.8799.
Ashraf T, Afaque SM, Aziz R, Khan M, Achakzai AS, Lateef A, et al. clinical, angiographic characteristics and in-hospital outcomes of smoker and nonsmoker patients after primary percutaneous coronary intervention. Glob Heart 2019;14 3:335–41. https://doi.org/10.1016/j.gheart.2019.07.007.
Ramotowski B, Undas A, Budaj A. altered platelet reactivity, coagulation, endothelial and inflammatory markers early after smoking cessation verified with cotinine plasma concentration. Eur Heart J 2022. https://doi.org/10.1093/eurheartj/ehac544.2385.
Koh D, Choi S, Park J-H, Lee S, Kim H-C, Kim I, et al. evaluation on the sex-specific association between cigarette smoke exposure and inflammation markers - c-reactive protein and white blood cell count. Nicotine Tob Res 2023. https://doi.org/10.1093/ntr/ntad182.
Khoso AA, Soomro GH, Mal SB, Malik R, Hanif B, Khan R. frequency, risk factors, and outcome of definite stent thrombosis: a single-center experience. Cureus 2022. https://doi.org/10.7759/cureus.27240.
Forero MT, Zanchin T, Masdjedi K, Van Zandvoort L, Kardys I, Zijlstra F, et al. incidence and predictors of outcomes after a first definite coronary stent thrombosis. EuroIntervention 2020. https://doi.org/10.4244/EIJ-D-19-00219.
Limpijankit T, Chandavimol M, Srimahachota S, Siriyotha S, Thakkinstian A, Krittayaphong R, et al. no paradoxical effect of smoking status on recurrent cardiovascular events in patients following percutaneous coronary intervention: thai pci registry. Front Cardiovasc Med 2022;9. https://doi.org/10.3389/fcvm.2022.888593.
Wu H-P, Jan S, Chang S, Huang C-C, Lin M-J. correlation between smoking paradox and heart rhythm outcomes in patients with coronary artery disease receiving percutaneous coronary intervention. Front Cardiovasc Med 2022;9. https://doi.org/10.3389/fcvm.2022.803650.
Sajjad W, Nawaz T, Ali H, Amin M, Hussain S. outcome of primary percutaneous coronary intervention for stemi due to stent thrombosis. J Heal Rehabil Res 2024;4:573–7. https://doi.org/10.61919/jhrr.v4i1.477.
Morita F, Wajngarten M, Katz M, Fernandes-Silva M, Caixeta A, Franken M, et al. short- and midterm adherence to platelet p2y12 receptor inhibitors after percutaneous coronary intervention with drug-eluting stents. J Cardiovasc Pharmacol Ther 2020;25:466–71. https://doi.org/10.1177/1074248420926667
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
